A new germline mutation, R600Q, within the coding region ofRET proto-oncogene: A rare polymorphism or a MEN 2 causing mutation? [PDF]
Marie-Laure Sez+6 more
openalex +1 more source
Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC) [PDF]
Sabine Glasl+4 more
openalex +1 more source
Abstract Background PARP (poly(ADP‐ribose) polymerase) inhibitors (PARPi) are now standard of care in metastatic castrate‐resistant prostate cancer (mCRPC) patients with select mutations in DNA damage repair (DDR) pathways, but patients with ATM‐ and BRCA2 mutations may respond differently to PARPi.
Christopher T. Su+21 more
wiley +1 more source
ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility
Annegien Broeks+9 more
openalex +1 more source
Discovery of germline and somatic mutations in apparently sporadic parathyroid tumours [PDF]
S. Uchino+8 more
openalex +1 more source
Germline Mutations in BMPR1A/ALK3 Cause a Subset of Cases of Juvenile Polyposis Syndrome and of Cowden and Bannayan-Riley-Ruvalcaba Syndromes* [PDF]
Xiaoping Zhou+28 more
openalex +1 more source
Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method [PDF]
Silvia Casadei+6 more
openalex +1 more source
Familial gastrointestinal stromal tumor with hyperpigmentation: Association with a germline mutation of the c-kit gene [PDF]
Hironobu Maeyama+15 more
openalex +1 more source
Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution
Abstract Prostate cancer is a common malignancy that in 5%–30% leads to treatment‐resistant and highly aggressive disease. Metastasis‐potential and treatment‐resistance is thought to rely on increased plasticity of the cancer cells—a mechanism whereby cancer cells alter their identity to adapt to changing environments or therapeutic pressures to create
Kira Furlano+6 more
wiley +1 more source